by James DeFranco | Mar 17, 2022 | Drug Price Transparency, Uncategorized, Virginia
Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st Written-by: Deneen Fumich, RPh March 2021, Virginia passed the Prescription Drug Price Transparency Regulation requiring pharmaceutical manufacturers to annually report prescription drug...
by James DeFranco | Feb 28, 2022 | Uncategorized
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities? Written-by: Deneen Fumich, RPh With the wave of 2021 passed Drug Price Transparency “DPT” laws now moving into rulemaking, is the industry finding it difficult to determine who a “Reporting...
by James DeFranco | Feb 25, 2022 | Uncategorized
Importance of Current Good Manufacturing Practices (cGMP) Written-by: Deneen Fumich, RPh Did you know that a common cause of failing FDA inspections is a gap in or the outdated training of employees in current good manufacturing practices (cGMP) compliance, as well as...
